scholarly journals Incidence of Anal Fistula After Pyogenic Perianal Abscess Drainage in Kingdom of Bahrain

2021 ◽  
Author(s):  
Zahra Abdulla Isa Yusuf Hasan ◽  
Bayan Mohamed ◽  
Rawaa AlSayegh ◽  
Raed AlMarzooq
Keyword(s):  
Anal Fistula ◽  
Perianal Abscess ◽  
Abscess Drainage

scholarly journals Incidence of Anal Fistula and Recurrent Abscesses following Management of Perianal Abscess

2016 ◽  
Vol 12 (2) ◽  
pp. 26-29
Author(s):  
Nasrin Begum ◽  
Quazi Sabran Uddin Ahmed
Keyword(s):  
Anal Fistula ◽  
Bacterial Overgrowth ◽  
Perianal Abscess ◽  
Armed Forces ◽  
Fistula Formation ◽  
Military Hospital ◽  
Abscess Drainage ◽  
Monthly Basis ◽  
Incision And Drainage ◽  
Drainage Group

Introduction: Most perianal abscesses originate from an infected anal gland. Obstruction of these glands leads to stasis, bacterial overgrowth and ultimately abscess. Approximately 10% of perirectal abscesses are thought not to be due to infected anal glands. It is unclear why some patients completely heal and others have recurrent disease. Objective: To assess the incidence of anal fistula and recurrent abscess after incision and drainage of perianal abscess. Materials and Methods: A prospective observational study was done on 140 patients operated upon for perianal abscess in Combined Military Hospital, Dhaka. They underwent for one group only drainage, for other group drainage with primary fistulotomy under general or spinal anesthesia over two years from January 2015 to December 2016. The patients were followed up for an average 13 months (range, 4-18 months) after abscess drainage or until a fistula appears and abscess recurs. Their duration of hospital stay was 1–3 days. After discharge from hospital, they were examined in follow-up within 7 to 14 days. Subsequently, they were examined on a monthly basis until drainage ceased or until it became obvious that a fistula-in-ano had developed. Results: Total 140 patients were treated for perianal abscess. Those patients were divided into two groups. The first group of 84 patients (60%) who underwent incision and drainage only. The second group consisted of 56(40%) patients who had low fistulas identified at the time of abscess drainage and underwent primary fistulotomy. The incidence of fistula formation after the operative procedures were 37(44.05%) in incision and drainage group and 5(8.93%) were in primary fistulotomy group. The most common site of abscess formation was posterior to anus. The incidence of recurrent abscess were 7(8.33%) in incision and drainage group; 2(3.57%) in primary fistulotomy group. The overall fistula formation (44.05% and 8.93%) and recurrence of abscess (8.33% and 3.57%) is low in primary fistulotomy group. Conclusion: In this study the overall incidence of anal fistula is much higher than recurrence of perianal abscess following management of perianal abscess. Primary fistulolotomy at the time of drainage for perianal abscess reslult in a fewer persistent fistulas and recurrence of abscess. Journal of Armed Forces Medical College Bangladesh Vol.12(2) 2016: 26-29

Crohn's Anal Fistula and Perianal Abscess: Results of Surgical Treatment

2007 ◽  
Vol 23 (6) ◽  
pp. 424 ◽  
Author(s):  
In Seob Lee ◽  
Eun Kyung Choe ◽  
Sung Chan Park ◽  
Kyu Joo Park
Keyword(s):  
Surgical Treatment ◽  
Anal Fistula ◽  
Perianal Abscess

Who Is At Risk for Developing Chronic Anal Fistula or Recurrent Anal Sepsis After Initial Perianal Abscess?

2009 ◽  
Vol 52 (2) ◽  
pp. 217-221 ◽  
Author(s):  
Ali Hamadani ◽  
Philip I. Haigh ◽  
In-Lu A. Liu ◽  
Maher A. Abbas
Keyword(s):  
At Risk ◽  
Anal Fistula ◽  
Perianal Abscess ◽  
Anal Sepsis

Role of interleukin-17 in the pathogenesis of perianal abscess and anal fistula: a clinical study on 50 patients with perianal abscess

2018 ◽  
Vol 89 (3) ◽  
pp. 244-247
Author(s):  
Jian-Ping Wang ◽  
Cheng Cai ◽  
Jin-Lin Du ◽  
Hong-Qi Shi ◽  
Qing-Wei Liu ◽  
...  
Keyword(s):  
Clinical Study ◽  
Anal Fistula ◽  
Perianal Abscess ◽  
Interleukin 17

Efficacy and Safety of Thalidomide in Crohn’s Disease Patients with Perianal Fistula and Abscess

2021 ◽  
Author(s):  
Zhenyi Tian ◽  
Lingying Ning ◽  
Rui Feng ◽  
Shu Xu ◽  
Baili Chen ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Adverse Effects ◽  
Disease Activity ◽  
Activity Index ◽  
Perianal Fistula ◽  
Perianal Abscess ◽  
Disease Activity Index ◽  
Abscess Drainage ◽  
Thalidomide Treatment

Abstract Background Medical therapies of parianal Crohn’s disease (CD) are limited. Thalidomide is an effective medical therapy to alleviate disease activity of CD. However, the effects and safety of thalidomide in the treatment of perianal fistula and abscess was not evaluated. Methods This retrospective cohort study was performed at a tertiary referral centre and recruited 73 patients with perianal CD who received thalidomide (50–100 mg) daily for 1 year. Data collected included demographics, medications, and disease behaviour. Clinical assessment of CD was conducted using the Crohn’s Disease Activity Index (CDAI), and perianal lesions were evaluated using the Fistula Drainage Assessment index and Perianal Disease Activity Index (PDAI). At the same time, the occurrence of adverse effects was recorded during treatment. Wilcoxon's signed-rank test and Student’s t-test were used to analyse the data. Results The CDAI score and laboratory indices were significantly lower after thalidomide treatment than at baseline (all P < 0.01). The value of PDAI was significantly lower in patients with symptomatic perianal abscess after thalidomide treatment than at baseline (10 [6.25, 10] versus 2.5 [1, 3.75]; P = 0.05). PDAI was also significantly reduced in all patients treated with thalidomide whether with or without perianal abscess drainage (all P < 0.05). The rates of responsive patients were similar between the thalidomide group and thalidomide combined with azathioprine group (72.73% [8/11] and 84% [21/25], respectively; P = 0.65). In total, 31% (24/77) of patients experienced adverse events, and interventions were required in 15 patients to reduce or eliminate discomfort from adverse events. Four patients discontinued thalidomide due to adverse effects. Side effects (rash, diarrhoea, peripheral neuropathy, somnolence, constipation, and numbness) were mild and mostly transient. Conclusions Thalidomide is effective in inducing clinical remission and response in CD patients with perianal fistula and abscess with or without abscess drainage. Thalidomide in combination with azathioprine is also effective in these patients. Low-dose thalidomide is proven to be effective and safe in treating perianal CD patients.

scholarly journals Can the risk of anal fistula development after perianal abscess drainage be reduced?

2020 ◽  
Vol 66 (8) ◽  
pp. 1082-1086
Author(s):  
Feridun Suat Gokce ◽  
Aylin Hande Gokce
Keyword(s):  
Body Mass Index ◽  
Body Mass ◽  
Perianal Fistula ◽  
Perianal Abscess ◽  
Fistula Formation ◽  
Abscess Drainage ◽  
Group 2 ◽  
Lost Work Time ◽  
Group 1

SUMMARY OBJECTIVE Perianal abscesses are frequently seen in clinical practice, and perianal fistulas develop in 30%–50% of cases after treatment. This study investigated whether the type of dressing applied after abscess drainage is correlated with fistula development. Prevention of fistula formation would reduce both the loss of work and healthcare costs. METHODS The records of patients who underwent drainage of perianal abscesses between January 2015 and January 2018 were retrospectively reviewed. Patients with postoperative dressings changed with washing of the area in the hospital were included as Group 1. Patients with dressings changed at home and the area bathed in 10% povidone-iodine sitz bath were included as Group 2. The frequency and time of fistula formation, age, sex, cost, and workdays lost in the two groups were compared. RESULTS Between-group differences in age, sex, body mass index, and type of fistula that developed after months and 1 year of the abscess drainage were not statistically significant (p > 0.05). During follow-up, fistula development was significantly lower in Group 1 than in Group 2 (p < 0.001). The risk of perianal fistula development was significantly increased in those with a body mass index (BMI) > 30 (p = 0.004). CONCLUSIONS After perianal abscess drainage, in-hospital washing and dressing of the abscess area until abscess closure reduced the risk of perianal fistula, lost work time, and cost. The risk of perianal fistula development appeared to increase with BMI. A large, prospective study is needed for confirmation.

scholarly journals EFFECTS OF CLOSURE OR EXCISION OF THE PRIMARY OPENING FOR ANAL FISTULA AND PERIANAL ABSCESS

2003 ◽  
Vol 64 (4) ◽  
pp. 805-810 ◽  
Author(s):  
Yoshihiro OHMI ◽  
Haruki YAMADA ◽  
Toshiaki JO ◽  
Masahiko FUKANO
Keyword(s):  
Anal Fistula ◽  
Perianal Abscess ◽  
Primary Opening
Sign in / Sign up

Export Citation Format

Share Document